发明授权
- 专利标题: Ribozyme therapy for the inhibition of restenosis
- 专利标题(中): 核酶治疗抑制再狭窄
-
申请号: US527060申请日: 1995-09-12
-
公开(公告)号: US5834440A公开(公告)日: 1998-11-10
- 发明人: Tsvi Goldenberg , Richard Tritz
- 申请人: Tsvi Goldenberg , Richard Tritz
- 申请人地址: CA San Diego
- 专利权人: Immusol Incorporated
- 当前专利权人: Immusol Incorporated
- 当前专利权人地址: CA San Diego
- 主分类号: C12N15/09
- IPC分类号: C12N15/09 ; A61K31/00 ; A61K31/70 ; A61K31/7088 ; A61K35/12 ; A61K35/76 ; A61K38/00 ; A61K48/00 ; A61P9/00 ; A61P9/10 ; C07H21/04 ; C12N5/10 ; C12N9/00 ; C12N15/113 ; C12N15/85 ; C12Q1/68
摘要:
As an effective therapy for restenosis, this invention provides ribozymes and ribozyme delivery systems useful to inhibit abnormal smooth muscle cell proliferation in vascular tissue. Methods of producing ribozymes and gene therapy utilizing these ribozymes also are provided.
公开/授权文献
- US5038421A Sofabed 公开/授权日:1991-08-13